Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
4 papers
Recent·Most cited
H. Khawaja, R. Briggs, C. Latimer…·S. Van Schaeybroeck
This study identifies Bcl-xL as a mediator of resistance to KRASG12C inhibitors in colorectal cancer and shows that combining Bcl-xL inhibition with KRASG12C inhibition enhances apoptosis and reduces tumor growth.
M. Russo, S. Pompei, A. Sogari…·M. C. Lagomarsino
The paper shows that drug treatment induces colorectal cancer persister cells with significantly increased mutation rates, suggesting new strategies to prevent tumor recurrence.
G. Rospo, A. Lorenzato, N. Amirouchene-Angelozzi…·A. Bardelli
This study tracks neoantigen profiles in colorectal cancers with DNA repair defects, finding dynamic patterns linked to antigen presentation downregulation and evolvability.
P. D. Dunne, H. G. Coleman, P. Bankhead…·M. Lawler
The paper identifies Bcl-xL as a prognostic biomarker and predictor of response to adjuvant chemotherapy in BRAF-mutant stage II/III colon cancer using gene expression and immunohistochemistry validation.